BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36252203)

  • 1. Cell cultures in assessing radioresistance of glioblastomas.
    Belyashova AS; Galkin MV; Antipina NA; Pavlova GV; Golanov AV
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):126-132. PubMed ID: 36252203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch promotes radioresistance of glioma stem cells.
    Wang J; Wakeman TP; Lathia JD; Hjelmeland AB; Wang XF; White RR; Rich JN; Sullenger BA
    Stem Cells; 2010 Jan; 28(1):17-28. PubMed ID: 19921751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
    Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
    J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.
    Besse A; Sana J; Fadrus P; Slaby O
    Tumour Biol; 2013 Aug; 34(4):1969-78. PubMed ID: 23568705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation.
    Kao GD; Jiang Z; Fernandes AM; Gupta AK; Maity A
    J Biol Chem; 2007 Jul; 282(29):21206-12. PubMed ID: 17513297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells.
    Orizio F; Triggiani L; Colosini A; Buglione M; Pasinetti N; Monti E; Bresciani R
    Biochem Biophys Res Commun; 2019 Jan; 508(1):31-36. PubMed ID: 30466783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.
    Fedrigo CA; Grivicich I; Schunemann DP; Chemale IM; dos Santos D; Jacovas T; Boschetti PS; Jotz GP; Braga Filho A; da Rocha AB
    Radiat Oncol; 2011 Nov; 6():156. PubMed ID: 22077956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status.
    Li W; Guo F; Wang P; Hong S; Zhang C
    Curr Mol Med; 2014 Jan; 14(1):185-95. PubMed ID: 24295494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
    Zhang Y; Zheng L; Ding Y; Li Q; Wang R; Liu T; Sun Q; Yang H; Peng S; Wang W; Chen L
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1132-1140. PubMed ID: 26031366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.
    Jiang Z; Pore N; Cerniglia GJ; Mick R; Georgescu MM; Bernhard EJ; Hahn SM; Gupta AK; Maity A
    Cancer Res; 2007 May; 67(9):4467-73. PubMed ID: 17483362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
    Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
    Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
    Yacoub A; Mitchell C; Lebedeva IV; Sarkar D; Su ZZ; McKinstry R; Gopalkrishnan RV; Grant S; Fisher PB; Dent P
    Cancer Biol Ther; 2003; 2(4):347-53. PubMed ID: 14508103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
    Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
    Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.
    Chappell WH; Steelman LS; Long JM; Kempf RC; Abrams SL; Franklin RA; Bäsecke J; Stivala F; Donia M; Fagone P; Malaponte G; Mazzarino MC; Nicoletti F; Libra M; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Milella M; Tafuri A; Bonati A; Evangelisti C; Cocco L; Martelli AM; McCubrey JA
    Oncotarget; 2011 Mar; 2(3):135-64. PubMed ID: 21411864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2014 Oct; 5(10):e1437. PubMed ID: 25275598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).
    Fang J; Zhou SH; Fan J; Yan SX
    Mol Med Rep; 2015 Mar; 11(3):1573-81. PubMed ID: 25376370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells.
    Chang JH; Hwang YH; Lee DJ; Kim DH; Park JM; Wu HG; Kim IA
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):412-20. PubMed ID: 26678661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
    Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
    J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.